Israel Englander Kymera Therapeutics, Inc. Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $189,829 - $299,924	9,700 Added 23.89%	50,300 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $848,946 - $1.39 Million	40,600 New	40,600 $884,000

160

63.1M

22.6K

14.4K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.72B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.